retatrutide clinical trials efficacy (RETA) is one of the most promising investigational peptides in obesity research— retatrutide clinical trials safety efficacy

Gastrointestinal adverse events, including diarrhoea, nausea, and vomiting, were consistently the most common side effects reported across all dose groups in the phase 2 trial

Crewe C, An YA, Scherer PE

This is a class effect shared across all GLP-1 receptor agonists , not a flaw in any particular medication

Starting with a lower dose helps your body adjust gradually, and most patients see improvements over time

La semaglutida tambin ayuda a reducir el riesgo de falla renal, tener que recibir dilisis, y las muertes relacionadas con la falla de los riones

NAION involves a sudden, painless loss of vision in one eye caused by reduced blood flow to the optic nerve